What is Proassurance Cp's earnings per share (EPS)?

Proassurance Cp (PRA) reported diluted earnings per share of $0.99 for fiscal year 2025. This represents a -3.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Proassurance Cp (PRA) Financials

PRA

Trailing 12 months to March 31, 2026

Revenue $1.1B -4.3% YoY

Net Income $65.2M +54.1% YoY

EPS (Diluted) $1.26 +51.8% YoY

Operating Cash Flow -$35.3M -231.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRA SEC filings page.

Proassurance Cp (PRA) reported $1.1B in revenue over the twelve months to Mar 31, 2026, down 4.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PRA FY2025 2026-08-29

Negative operating cash flow keeps reported profitability separate from the business's underlying cash economics.

In FY2025, net income was $50.9M while operating cash flow was -$25.6M; the gap means reported profit did not translate into cash from operations. This is not a one-year anomaly: operating cash flow was also negative in FY2023 and FY2024 as earnings moved from losses to profits, making earnings quality the central issue visible in the data.

Total liabilities fell from $4.52B in FY2023 to $4.10B in FY2025, reducing the obligations supported by the asset base. Debt-to-equity moved from 0.4x to 0.3x, indicating a less debt-dependent financing posture even though operating cash flow remained negative.

Revenue declined 4.6% from FY2024 to FY2025, yet net margin held nearly flat at 4.6%, so the latest profitability was not created by top-line expansion. Return on assets was 0.9% against a 4.6% net margin, showing that the balance sheet is much larger than the income statement alone suggests and that capital efficiency remains restrained.

Financial Health Signals

Financial Health Score 24/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Proassurance Cp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Proassurance Cp scores 20/100 on it among other insurers.

Premium Growth

Proassurance Cp reported revenue of $1.1B in fiscal year 2025, against $1.2B in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Proassurance Cp scores 14/100 among other insurers.

Capital

Proassurance Cp funded 24.8% of its assets with shareholders' equity at the end of fiscal year 2025, holding $1.3B of equity against $5.4B of assets. Capital ranks insurers on that cushion, and Proassurance Cp scores 51/100 among other insurers.

Investment Yield

Not available for Proassurance Cp, and counted as zero in the overall score.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Proassurance Cp scores 32/100 on it among other insurers.

Stability

Proassurance Cp reported net income of $50.9M in fiscal year 2025, against $52.7M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Proassurance Cp scores 24/100 among other insurers.

Piotroski F-Score Partial

1/7

Proassurance Cp passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

$0.50used

For every $1 of reported earnings, Proassurance Cp used $0.50 of operating cash (-$25.6M OCF vs $50.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$262.6M

YoY-3.5%

QoQ-2.6%

5Y CAGR+3.6%

10Y CAGR+3.1%

Proassurance Cp generated $262.6M in revenue in Q1 2026. This represents a decrease of 3.5% from the same quarter a year earlier. Against the prior quarter it is down 2.6%.

Net Income

$8.5M

YoY+245.3%

QoQ-74.6%

5Y CAGR+1.8%

10Y CAGR-7.9%

Proassurance Cp reported $8.5M in net income in Q1 2026. This represents an increase of 245.3% from the same quarter a year earlier. Against the prior quarter it is down 74.6%.

EPS (Diluted)

$0.16

YoY+245.5%

QoQ-75.4%

5Y CAGR+2.7%

10Y CAGR-7.8%

Proassurance Cp earned $0.16 per diluted share (EPS) in Q1 2026. This represents an increase of 245.5% from the same quarter a year earlier. Against the prior quarter it is down 75.4%.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$14.1M

YoY-67.7%

QoQ-61.5%

5Y CAGR-42.0%

10Y CAGR-23.2%

Proassurance Cp held $14.1M in cash against $419.3M in long-term debt as of Q1 2026.

Shares Outstanding

52M

YoY+0.6%

QoQ+0.4%

5Y CAGR-0.9%

10Y CAGR-0.3%

Proassurance Cp had 52M shares outstanding in Q1 2026. This represents an increase of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin

3.2%

YoY+5.4pp

QoQ-9.2pp

5Y CAGR-0.3pp

10Y CAGR-6.8pp

Proassurance Cp's net profit margin was 3.2% in Q1 2026, showing the share of revenue converted to profit. This is up 5.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.2 percentage points.

Return on Equity

0.6%

YoY+1.1pp

QoQ-1.8pp

5Y CAGR0.0pp

10Y CAGR-0.3pp

Proassurance Cp's ROE was 0.6% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

PRA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRA quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.1B	$1.1B-4.6%	$1.2B+1.2%	$1.1B+2.8%	$1.1B-1.6%	$1.1B+28.5%	$874.9M-12.5%	$999.8M+12.8%	$886.0M+2.3%	$866.1M-0.5%	$870.2M+12.7%	$772.1M-9.4%	$852.3M+15.2%	$740.2M+3.4%	$715.9M-0.1%	$716.8M
Interest Expense	$20.8M	$20.8M-6.7%	$22.3M-3.5%	$23.1M+13.6%	$20.4M+3.3%	$19.7M+27.2%	$15.5M-6.8%	$16.6M+3.2%	$16.1M-4.3%	$16.8M+12.1%	$15.0M+3.0%	$14.6M+3.6%	$14.1M+411.2%	$2.8M+26.3%	$2.2M-37.3%	$3.5M
Income Tax	$22.4M	$21.2M+104.7%	$10.3M+1996.1%	-$545K+90.6%	-$5.8M-334.2%	$2.5M+106.0%	-$41.3M-38.7%	-$29.8M-65.3%	-$18.0M-184.4%	$21.4M-15.0%	$25.1M+98.5%	$12.7M-80.7%	$65.4M-34.3%	$99.6M-17.3%	$120.5M-5.5%	$127.5M
Net Income	$65.2M	$50.9M-3.5%	$52.7M+236.6%	-$38.6M-9503.0%	-$402K-100.3%	$144.1M+182.0%	-$175.7M-17602.7%	$1.0M-97.9%	$47.1M-56.1%	$107.3M-29.0%	$151.1M+30.0%	$116.2M-40.9%	$196.6M-33.9%	$297.5M+8.0%	$275.5M-4.0%	$287.1M
EPS (Basic)	N/A	$0.99-3.9%	$1.03+241.1%	-$0.73-7200.0%	-$0.01-100.4%	$2.67+181.9%	-$3.26-16400.0%	$0.02-97.7%	$0.88-56.2%	$2.01-29.2%	$2.84+34.0%	$2.12-36.1%	$3.32-31.1%	$4.82+7.3%	$4.49-4.5%	$4.70
EPS (Diluted)	$1.26	$0.99-3.9%	$1.03+241.1%	-$0.73-7200.0%	-$0.01-100.4%	$2.67+181.9%	-$3.26-16400.0%	$0.02-97.7%	$0.88-56.0%	$2.00-29.3%	$2.83+34.1%	$2.11-36.1%	$3.30-31.3%	$4.80+7.6%	$4.46	$4.65
Diluted Shares (Avg)	N/A	52M+0.8%	51M-2.9%	53M-2.5%	54M+0.2%	54M+0.3%	54M+0.1%	54M+0.2%	54M+0.3%	54M+0.3%	53M-2.9%	55M-7.6%	60M-4.0%	62M+0.3%	62M	62M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$262.6M-3.5%	$269.6M-7.1%	$279.6M-2.0%	$276.8M-4.7%	$272.1M-4.4%	$290.1M-2.3%	$285.3M+3.4%	$290.4M-0.5%
Interest Expense	$5.1M-1.4%	$5.2M-2.3%	$5.2M-8.1%	$5.2M-7.5%	$5.2M-8.8%	$5.3M-20.0%	$5.7M+3.3%	$5.6M+2.7%
Income Tax	$732K+243.5%	$13.2M+415.9%	$2.9M-37.2%	$5.5M+127.8%	-$510K-173.7%	$2.6M-23.6%	$4.7M+200.0%	$2.4M-17.3%
Net Income	$8.5M+245.3%	$33.4M+106.4%	$1.4M-91.2%	$21.9M+41.4%	-$5.8M-225.9%	$16.2M+153.6%	$16.4M+133.3%	$15.5M+45.9%
EPS (Basic)	$0.16+245.5%	$0.65+109.7%	$0.03-90.6%	$0.43+43.3%	-$0.11-222.2%	$0.31+158.3%	$0.32+133.7%	$0.30+50.0%
EPS (Diluted)	$0.16+245.5%	$0.65+103.1%	$0.03-90.6%	$0.42+40.0%	-$0.11-222.2%	$0.32+166.7%	$0.32+133.7%	$0.30+50.0%
Diluted Shares (Avg)	52M+0.7%	N/A	52M+0.9%	52M+0.9%	51M+0.6%	N/A	51M-1.4%	51M-5.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

PRA Balance Sheet

PRA quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$5.4B-2.3%	$5.6B-1.0%	$5.6B-1.2%	$5.7B-7.9%	$6.2B+33.0%	$4.7B-3.1%	$4.8B+4.5%	$4.6B-6.7%	$4.9B-2.7%	$5.1B+3.2%	$4.9B-5.1%	$5.2B+0.4%	$5.2B+5.6%	$4.9B-2.4%	$5.0B
Cash & Equivalents	$36.5M-33.5%	$54.9M-16.7%	$65.9M+120.0%	$30.0M-79.1%	$143.6M-33.5%	$215.8M+23.0%	$175.4M+117.9%	$80.5M-40.2%	$134.5M+14.6%	$117.3M-51.3%	$241.1M+22.4%	$197.0M+52.3%	$129.4M+9.1%	$118.6M-9.1%	$130.4M
Short-Term Investments	$285.6M+12.0%	$254.9M+8.1%	$235.8M-3.9%	$245.3M+13.1%	$217.0M-35.8%	$337.8M-0.6%	$339.9M+10.2%	$308.3M-28.7%	$432.1M-2.3%	$442.1M+270.8%	$119.2M-9.2%	$131.3M-47.2%	$248.6M+246.6%	$71.7M-39.9%	$119.4M
Long-Term Investments	$8.4M+15.6%	$7.3M-89.0%	$65.8M-31.3%	$95.8M-5.9%	$101.8M+116.3%	$47.1M+20.8%	$38.9M+13.6%	$34.3M	$0	$0	$0	$0	$0	$0	$0
Goodwill	$5.5M0.0%	$5.5M0.0%	$5.5M-88.9%	$49.6M0.0%	$49.6M0.0%	$49.6M-76.5%	$210.7M0.0%	$210.7M0.0%	$210.7M0.0%	$210.7M0.0%	$210.7M0.0%	$210.7M+30.8%	$161.1M-1.2%	$163.1M+2.1%	$159.6M
Total Liabilities	$4.1B-6.3%	$4.4B-3.3%	$4.5B-1.7%	$4.6B-3.5%	$4.8B+44.1%	$3.3B+0.4%	$3.3B+7.0%	$3.1B-7.7%	$3.3B+2.1%	$3.3B+10.8%	$2.9B-2.1%	$3.0B+9.3%	$2.8B+5.7%	$2.6B-8.1%	$2.8B
Long-Term Debt	$420.4M-1.0%	$424.9M-0.5%	$427.1M0.0%	$427.0M+0.5%	$425.0M+49.3%	$284.7M-0.4%	$285.8M-0.7%	$287.8M-30.1%	$411.8M-8.1%	$448.2M	N/A	$250.0M0.0%	$250.0M+100.0%	$125.0M+151.6%	$49.7M
Total Equity	$1.3B+12.3%	$1.2B+8.1%	$1.1B+0.7%	$1.1B-22.7%	$1.4B+5.9%	$1.3B-10.8%	$1.5B-0.7%	$1.5B-4.5%	$1.6B-11.3%	$1.8B-8.2%	$2.0B-9.2%	$2.2B-9.9%	$2.4B+5.5%	$2.3B+4.9%	$2.2B
Retained Earnings	$1.5B+3.5%	$1.4B+3.8%	$1.4B-2.9%	$1.4B-0.8%	$1.4B+10.2%	$1.3B-13.6%	$1.5B-4.2%	$1.6B-2.6%	$1.6B-11.5%	$1.8B-8.2%	$2.0B-0.2%	$2.0B-1.2%	$2.0B+13.1%	$1.8B+4.9%	$1.7B

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$5.4B-2.0%	$5.4B-2.3%	$5.6B-3.1%	$5.5B-2.3%	$5.5B-2.2%	$5.6B-1.0%	$5.7B+2.8%	$5.6B-0.8%
Cash & Equivalents	$14.1M-67.7%	$36.5M-33.5%	$54.5M+20.2%	$41.6M+12.8%	$43.5M-33.4%	$54.9M-16.7%	$45.3M-27.1%	$36.9M-19.9%
Short-Term Investments	$309.5M+26.8%	$285.6M+12.0%	$291.3M+26.4%	$257.3M+17.2%	$244.0M+32.6%	$254.9M+8.1%	$230.6M-6.8%	$219.6M-30.4%
Long-Term Investments	$7.2M-7.6%	$8.4M+15.6%	$9.3M+51.1%	$7.8M+24.2%	$7.8M-87.0%	$7.3M-89.0%	$6.2M-90.2%	$6.3M-90.4%
Goodwill	$5.5M0.0%	$5.5M0.0%	$5.5M0.0%	$5.5M0.0%	$5.5M0.0%	$5.5M0.0%	$5.5M0.0%	$5.5M-88.9%
Total Liabilities	$4.1B-5.0%	$4.1B-6.3%	$4.2B-5.6%	$4.2B-6.1%	$4.3B-5.4%	$4.4B-3.3%	$4.5B-1.3%	$4.5B-1.2%
Long-Term Debt	$419.3M-1.0%	$420.4M-1.0%	$421.5M-1.0%	$422.6M-1.0%	$423.7M-0.9%	$424.9M-0.5%	$425.9M-0.1%	$426.9M+0.2%
Total Equity	$1.3B+8.5%	$1.3B+12.3%	$1.3B+5.9%	$1.3B+12.6%	$1.2B+10.8%	$1.2B+8.1%	$1.2B+21.7%	$1.1B+1.1%
Retained Earnings	$1.5B+4.6%	$1.5B+3.5%	$1.5B+2.4%	$1.5B+3.5%	$1.4B+3.1%	$1.4B+3.8%	$1.4B+3.1%	$1.4B-1.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

PRA Cash Flow Statement

PRA quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$35.3M	-$25.6M-139.1%	-$10.7M+78.5%	-$49.9M-67.2%	-$29.8M-140.3%	$74.0M-19.9%	$92.3M-37.7%	$148.2M-16.4%	$177.3M+2.2%	$173.4M-3.1%	$179.0M+61.1%	$111.1M+15.8%	$96.0M+148.7%	$38.6M-57.7%	$91.3M-42.7%	$159.4M
Depreciation & Amortization	N/A	$13.7M-22.9%	$17.8M-31.8%	$26.0M-31.7%	$38.1M+2.2%	$37.2M+74.3%	$21.4M+14.5%	$18.7M-12.2%	$21.3M-26.2%	$28.8M-12.2%	$32.8M-9.5%	$36.2M-8.5%	$39.6M+10.5%	$35.8M-4.6%	$37.6M+289.4%	$9.6M
Stock-Based Compensation	N/A	$7.8M+26.5%	$6.2M+18.2%	$5.2M+8.7%	$4.8M+10.0%	$4.4M+14.3%	$3.8M+8.9%	$3.5M-33.7%	$5.3M-49.9%	$10.6M-14.8%	$12.5M+35.9%	$9.2M-8.9%	$10.1M+8.8%	$9.2M+7.0%	$8.6M+21.4%	$7.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$9.6M-0.5%	$9.6M-8.1%	$10.5M-4.0%	$10.9M+14.7%	$9.5M+230.4%	$2.9M-50.7%	$5.8M	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$138.6M-17.3%	$167.6M+2.9%	$162.9M-3.1%	$168.1M+65.4%	$101.6M+9.1%	$93.1M+184.3%	$32.8M	N/A	N/A
Investing Cash Flow	$19.7M	$19.4M+82.1%	$10.7M-92.4%	$141.1M+327.7%	-$62.0M+27.5%	-$85.5M-908.1%	-$8.5M-116.8%	$50.5M-76.5%	$214.9M+7.3%	$200.3M+169.3%	-$288.8M-226.8%	$227.8M-14.7%	$267.0M+493.8%	-$67.8M-352.6%	$26.8M+154.1%	-$49.6M
Financing Cash Flow	-$13.9M	-$12.2M-11.2%	-$11.0M+80.2%	-$55.3M-153.7%	-$21.8M+64.0%	-$60.6M-39.5%	-$43.4M+58.1%	-$103.8M+76.7%	-$446.2M-25.2%	-$356.5M-2458.6%	-$13.9M+95.3%	-$294.9M+0.2%	-$295.3M-837.7%	$40.0M+130.8%	-$129.9M-330.2%	-$30.2M
Dividends Paid	N/A	$0	$0-100.0%	$5.4M-50.0%	$10.8M+0.1%	$10.8M-72.2%	$38.7M-58.5%	$93.2M-70.5%	$316.5M+0.4%	$315.2M+165.3%	$118.8M-45.4%	$217.6M+205.4%	$71.3M+53.6%	$46.4M-76.8%	$200.1M+2527.3%	$7.6M
Share Buybacks	N/A	N/A	N/A	$50.5M+1452.5%	$3.3M	$0	$0	N/A	$0	$0-100.0%	$2.1M-98.8%	$172.8M-22.3%	$222.4M+664.4%	$29.1M	$0-100.0%	$21.0M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$21.3M-83.7%	-$13.1M-5422.7%	$27.2M+94.0%	-$28.1M-118.4%	-$11.6M+0.3%	-$238K+92.7%	$14.0M-7.8%	-$12.8M+59.8%
Depreciation & Amortization	$2.9M-23.8%	$3.0M-26.5%	$3.3M-14.7%	$3.5M-20.1%	$3.8M-28.3%	$4.1M-30.8%	$3.9M-39.9%	$4.4M-25.5%
Stock-Based Compensation	$2.3M+27.0%	N/A	N/A	N/A	$1.8M+89.2%	N/A	N/A	N/A
Investing Cash Flow	$4.4M+6.8%	-$1.4M-108.7%	-$13.4M-256.1%	$30.1M+313.8%	$4.1M-66.1%	$16.4M+331.0%	-$3.8M-112.0%	-$14.1M-130.5%
Financing Cash Flow	-$5.5M-43.4%	-$3.4M+48.4%	-$978K+47.0%	-$4.0M-152.3%	-$3.8M-296.4%	-$6.6M-303.7%	-$1.8M+94.0%	-$1.6M+93.6%
Dividends Paid	N/A	N/A	N/A	N/A	N/A	$0	$0	$0-100.0%
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	N/A

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

PRA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRA quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	4.6%+0.1pp	4.6%+8.0pp	-3.4%-3.4pp	0.0%-12.9pp	12.8%+32.9pp	-20.1%-20.2pp	0.1%-5.2pp	5.3%-7.1pp	12.4%-5.0pp	17.4%+2.3pp	15.0%-8.0pp	23.1%-17.1pp	40.2%+1.7pp	38.5%-1.6pp	40.1%
Return on Equity	3.8%-0.6pp	4.4%+7.9pp	-3.5%-3.4pp	0.0%-10.1pp	10.1%+23.1pp	-13.0%-13.1pp	0.1%-3.0pp	3.1%-3.6pp	6.7%-1.7pp	8.4%+2.5pp	5.9%-3.2pp	9.1%-3.3pp	12.4%+0.3pp	12.1%-1.1pp	13.3%
Return on Assets	0.9%0.0pp	0.9%+1.6pp	-0.7%-0.7pp	0.0%-2.3pp	2.3%+6.1pp	-3.8%-3.8pp	0.0%-1.0pp	1.0%-1.2pp	2.2%-0.8pp	3.0%+0.6pp	2.4%-1.4pp	3.8%-2.0pp	5.8%+0.1pp	5.7%-0.1pp	5.7%
Debt-to-Equity	0.310.0x	0.350.0x	0.380.0x	0.39+0.1x	0.30+0.1x	0.210.0x	0.190.0x	0.19-0.1x	0.260.0x	0.25-1.3x	1.51+1.4x	0.120.0x	0.100.0x	0.060.0x	0.02
Asset Turnover	0.200.0x	0.210.0x	0.200.0x	0.190.0x	0.180.0x	0.190.0x	0.210.0x	0.190.0x	0.180.0x	0.170.0x	0.160.0x	0.160.0x	0.140.0x	0.150.0x	0.14
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	13.9%-5.1pp	18.9%+0.1pp	18.8%-0.5pp	19.3%+6.2pp	13.2%+2.2pp	10.9%+6.5pp	4.4%	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	3.2%+5.4pp	12.4%+6.8pp	0.5%-5.2pp	7.9%+2.6pp	-2.1%-3.8pp	5.6%+3.4pp	5.8%+23.7pp	5.3%+1.7pp
Return on Equity	0.6%+1.1pp	2.5%+1.1pp	0.1%-1.2pp	1.7%+0.3pp	-0.5%-0.9pp	1.4%+0.8pp	1.3%+6.2pp	1.4%+0.4pp
Return on Assets	0.2%+0.3pp	0.6%+0.3pp	0.0%-0.3pp	0.4%+0.1pp	-0.1%-0.2pp	0.3%+0.2pp	0.3%+1.2pp	0.3%+0.1pp
Debt-to-Equity	0.310.0x	0.310.0x	0.320.0x	0.330.0x	0.340.0x	0.350.0x	0.35-0.1x	0.380.0x
Asset Turnover	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x	0.050.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Proassurance Cp PRA	FY2025	$1.1B	$50.9M	4.6%	$1.3B	24/100
BOWHEAD SPECIALTY HLDGS INC BOW	FY2025	$551.6M	$53.8M	9.8%	$1.1B	48/100
Safety Ins Group Inc SAFT	FY2025	$1.3B	$99.3M	7.8%	$1.5B	45/100
Skyward Specialty Insurance Group Inc SKWD	FY2025	$1.4B	$170.0M	12.0%	$2.3B	42/100
Hippo Hldgs Inc HIPO	FY2025	$468.6M	$62.6M	13.4%	$894.6M	33/100
United Fire Group Inc UFCS	FY2025	$1.4B	$118.2M	8.5%	$1.4B	41/100

Where Proassurance Cp Ranks

Frequently Asked Questions

What is Proassurance Cp's annual revenue?

Proassurance Cp (PRA) reported $1.1B in total revenue for fiscal year 2025. This represents a -4.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Proassurance Cp's revenue growing?

Proassurance Cp (PRA) revenue declined by 4.6% year-over-year, from $1.2B to $1.1B in fiscal year 2025.

Is Proassurance Cp profitable?

Yes, Proassurance Cp (PRA) reported a net income of $50.9M in fiscal year 2025, with a net profit margin of 4.6%.

How much debt does Proassurance Cp have?

As of fiscal year 2025, Proassurance Cp (PRA) had $36.5M in cash and equivalents against $420.4M in long-term debt.

What is Proassurance Cp's net profit margin?

Proassurance Cp (PRA) had a net profit margin of 4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Proassurance Cp's return on equity (ROE)?

Proassurance Cp (PRA) has a return on equity of 3.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Proassurance Cp's operating cash flow?

Proassurance Cp (PRA) recorded an outflow of $25.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Proassurance Cp's total assets?

Proassurance Cp (PRA) had $5.4B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Proassurance Cp have outstanding?

Proassurance Cp (PRA) had 51M shares outstanding as of fiscal year 2025.

What is Proassurance Cp's debt-to-equity ratio?

Proassurance Cp (PRA) had a debt-to-equity ratio of 0.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Proassurance Cp's return on assets (ROA)?

Proassurance Cp (PRA) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Proassurance Cp's Piotroski F-Score?

Proassurance Cp (PRA) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Proassurance Cp's earnings high quality?

For every $1 of reported earnings, Proassurance Cp (PRA) used $0.50 of operating cash (-$25.6M OCF vs $50.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Proassurance Cp?

Proassurance Cp (PRA) scores 24 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.